Forbes October 31, 2024
Startup Ataraxis, which emerged from stealth Thursday, has developed a model that can predict the risk severity of breast cancer up to 30% more accurately than current tests.
One of the challenges of treating cancers is that they aren’t created equal. Some are fast and aggressive, others slow with lower risk. It’s often difficult to tell which is which, challenging to guide the course of treatment and leading to therapies whose risks outweigh the dangers of the cancer. There are some lab tests that can help, but it can take days or weeks to get results and their usefulness is sometimes specific to patients with specific genetic mutations.
Jan Witowski wants to change this. His company, Ataraxis, has developed an...
Today's Sponsors
Today's Sponsor